Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: Correlation with high density lipoproteins

Journal of the American College of Cardiology

Volumn 27, Issue 7, 1996, Pages 1562-1570

  Hausmann, Dirk ^a   Johnson, Jay A ^a   Sudhir, Krishnankutty ^a   Mullen, William L ^a   Friedrich, Guy ^a   Fitzgerald, Peter J ^a   Chou, Tony M ^a   Ports, Thomas A ^a   Kane, John P ^a   Malloy, Mary J ^a   Yock, Paul G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANGIOGRAPHY; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CORONARY ARTERY; ECHOGRAPHY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; HYPERLIPIDEMIA; ILIAC ARTERY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT CORONARY ARTERY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ARTERIOSCLEROSIS; CHOLESTEROL, HDL; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPOPROTEINEMIA TYPE II; ILIAC ARTERY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0029893460     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)00048-4     Document Type: Article

References (48)

1. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;4:758-65.
2. Holmes DR, Elveback LR, Frye RL, Kottke BA, Ellefson RD. Association of risk factor variables and coronary artery disease documented with angiography. Circulation 1981;63:293-9.
3. Maciejko JJ, Holmes DR, Kottke BA, Zinsmeister AR, Dinh DM, Mao SJT. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. N Engl J Med 1983;309:385-9.
4. Pearson TA, Bulkley BH, Achuff SC, Kwiterovich PO, Gordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am J Epidemiol 1979;109:285-95.
5. Kane JP, Malloy MJ, Ports TA, Phillips NR, Diehl JC, Havel RJ. Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens. JAMA 1990;264:3007-12.
6. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH: Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA 1990;264:3013-7.
7. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289-98.
8. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas atherosclerosis regression study (STARS). Lancet 1992;339:563-9.
9. Isner JM, Kishel J, Kent KM, Ronan JA, Ross AM, Roberts WC. Accuracy of angiographic determination of left main coronary arterial narrowing. Angiographic-histologic correlative analysis in 28 patients. Circulation 1981; 63:1056-64.
10. Arnett EN, Isner JM, Redwood DR, et al. Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med 1979;91:350-6.
11. Eusterman JH, Achor RWP, Kincaid OW, Brown AL. Atherosclerotic disease of the coronary arteries. A pathologic-radiologic correlative study. Circulation 1962;26:1288-95.
12. Freudenberg H, Lichtlen PR. The normal wall segment in coronary stenoses - a postmortal study. Z Kardiol 1981;70:863-9.
13. Stiel GM, Stiel LSG, Schofer J, Donath K, Mathey DG. Impact of compensatory enlargement of atherosclerotic coronary arteries on angiographic assessment of coronary artery disease. Circulation 1989;80:1603-9.
14. Hodgson JM, Graham SP, Savakus AD, et al. Clinical percutaneous imaging of coronary anatomy using an over-the-wire ultrasound catheter system. Int J Card Imaging 1989;4:187-93.
15. Pandian NG, Kreis A, Brockway B, et al. Ultrasound angioscopy: real-time, two-dimensional, intraluminal ultrasound imaging of blood vessels. Am J Cardiol 1988;62:493-4.
16. Nishimura RA, Edwards WD, Warnes CA, et al. Intravascular ultrasound imaging: in vitro validation and pathologic correlation. J Am Coll Cardiol 1990:16:145-54.
17. Potkin BN, Bartorelli AL, Gessert JM, et al. Coronary artery imaging with intravascular high-frequency ultrasound. Circulation 1990;81:1575-85.
18. Gussenhoven EJ, Essed CE, Lancee CT, et al. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. J Am Coll Cardiol 1989;14:947-52.
19. Tobis JM, Mallery JA, Gessert J. et al. Intravascular ultrasound cross-sectional arterial imaging before and after balloon angioplasty in vitro. Circulation 1989;80:873-82.
20. Fitzgerald PJ, Goar FG, Connolly RJ, et al. Intravascular ultrasound imaging of coronary arteries. Is three layers the norm. Circulation 1992;86:154-8.
21. Armstrong ML, Heistad DD, Marcus ML, Megan MB, Giegors DJ. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet. Arteriosclerosis 1985;5:336-46.
22. Weibel ER. Stereologic Methods: Practical Methods for Biological Morphometry. Vol. 1. London: Academic Press, 1979.
23. Newman WP, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 1986;314:138-44.
24. Myers LH, Phillips NR, Havel RJ. Mathematical evaluation of methods for estimation of the concentration of the major lipid components of human serum lipoproteins. J Lab Clin Med 1976;88:491-506.
25. Pagnan A, Havel RJ, Kane JP, Kotite L. Characterization of human very low density lipoproteins containing two electrophoretic populations: double pre-beta lipoproteinemia and primary dysbetalipoproteinemia. J Lipid Res 1977;18:613-22.
26. Rhoads GG, Morton NE, Gulbrandsen CL, Kagan A. Sinking pre-beta lipoprotein and coronary heart diseae in Japanese-American men in Hawaii. Am J Epidemiol 1978:108:350-6.
27. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987:316:1371-5.
28. McPherson DD, Hiratzka LF, Lamberth WC, et al. Delineation of the extent of coronary atherosclerosis by high-frequency epicardial echocardiography. N Engl J Med 1987:316:304-9.
29. Isner JM, Donaldson RF, Fortin AH, Tischler A, Clarke RH. Attenuation of the media of coronary arteries in advanced atherosclerosis. Am J Cardiol 1986;58:937-9.
30. Honye J, Mahon DJ, Jain A, et al. Morphological effects of coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation 1992;85:1012-25.
31. DiMario C, Madretsma S, Linker D, et al. The angle of incidence of the ultrasonic beam: a critical factor for the image quality in intravascular ultrasonography. Am Heart J 1993:125:442-8.
32. Clarkson TB, Bond MG, Bullock BC, Marzetta CA. A study of atherosclerosis regression in macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl. Exp Mol Pathol 1981;34:345-68.
33. Sudhir K, Ports TA, Amidon TM, et al. Increased prevalence of coronary ectasia in heterzygous familial hypercholesterolemia. Circulation 1995;91: 1375-80.
34. Blankenhorn DH, Azen SP, Crawford DW, et al. Effects of colestipol-Niacin therapy on human femoral atherosclerosis. Circulation 1991;83:438-47.
35. Holme I, Enger SC, Helgeland A, et al. Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis from the Oslo Study. Arteriosclerosis 1981;1:250-6.
36. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Relationship of atherosclerosis in young men to serum lipoprotein cholesterol concentrations and smoking. JAMA 1990;264:3018-24.
37. Gordon DJ, Knoke J, Probstfield JL, Superko R, Tyroler HA. High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial. Circulation 1986;74:1217-25.
38. Miller NE, Thelle DS, Foerde OH, Mjoes OD. The tromsoe heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet 1977;1:965-70.
39. Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA 1982;248:1465-77.
40. Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988;260:641-51.
41. Glomset JA. The plasma lecithin-cholesterol acyltransferase reaction. J Lipid Res 1968;9:155-67.
42. Fielding PE, Fielding CJ. Dynamics of lipoprotein transport in the circulatory system. In: Vance DE, Vance J, editors. Biochemistry of Lipids, Lipoproteins and Membranes. Amsterdam: Elsevier, 1991:427-59.
43. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities. J Lipid Res 1992;33:1807-16.
44. Parthasarathy S, Fong LG, Steinberg D. Inhibitory effect of high density lipoprotein (HDL) on oxidative modification of low density lipoprotein (LDL). Circulation 1987;76 Suppl IV:IV-479-92.
45. Kunitake ST, Jarvis M, Hamilton RL, Kane JP. Binding of transition metals by apolipoprotein A-I-containing lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci USA 1992;89:6993-7.
46. Klimov A, et al. Antioxidant effect of high density lipoproteins on peroxidation of low density lipoproteins. Eksper Biologii I Med 1987;103:510-59.
47. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-24.
48. Hausmann D, Fitzgerald PJ, Daniel WG, Yock PG, Ports TA, and the SAFETY of ICUS Study Group. Safety of intracoronary ultrasound: a multicenter, multicatheter registry in 1837 patients. Circulation 1995;91:623-30.